Table 1.
Baseline characteristics and outcome of all 135 individuals.
| Characteristic | Subjects N (%) |
|---|---|
| Age (years) | 68 ± 12 |
| Male (%) | 93 (69) |
| VKA use (%) | 12 (8.9) |
| Dialysis dependent (%)* | 3 (2.2) |
| Immunocompromised (%) | 6 (4.4) |
| Respiratory disease (%) | 40 (29.6) |
| Cardiac or cardiovascular disease (%) | 38 (28.1) |
| Laboratory parameters | N (Median; LQ-UQ) |
| IL-6, pg/mL | 133 (57; 26–153) |
| Desmosine, ng/L | 127 (353; 280–491) |
| Dp-ucMGP, pmol/L | 135 (1137.7; 816–1676) |
| Vitamin (25-OH)D, nmol/L | 133 (40.4; 27–66) |
| Outcome | N (%) |
| ICU admission (%) | 36 (26.7) |
| ICU admission and mechanical ventilation (%) | 32 (23.7) |
| Deceased (%) | 42 (31.1) |
| Poor outcome (%) | 60 (44.4) |
VKA, Vitamin K antagonist.
*
At admission.